…iotherapy with concurrent TMZ, the subjects receive intravenous certepetide or placebo alongside six cycles of adjuvant TMZ treatment. The …
All extracted drugs
Showing 1,141–1,200 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Articles mentioning drugs
10,506 articles · page 249 of 876… splenocytes. In vivo, tumor-bearing mice received intratumoral OAd.shDNMT1, systemic decitabine, or immune checkpoint inhibitors (anti-Pro…
…y relationship persisted on 30-day survival analysis.Conclusion REBOA for patients in shock after penetrating abdominal trauma is ass…
… current study was to investigate the proportion of UK SPs with OLO blood available for donation over a 5-year period and to identi…
…05).Conclusion Existing evidence does not clearly link maternal paracetamol use during pregnancy with autism or ADHD in offspring.Systemati…
…obstruction and transformation into malignant cancer can occur. Zopapogene imadenovec (PAPZIMEOSTM) , a novel HPV-Targeted Immuno-Activator, is the f…
… genomic profiling will be presented at the meeting.Conclusions Nivolumab demonstrated a high rate of clinical complete responses in pati…
…Background Invikafusp alfa (STAR0602), a selective, dual T cell agonist targeting Vβ6/10 T…
…ngoing; updated efficacy outcomes will be presented.Conclusions IDP-023 off-the-shelf allogeneic g-NK-cell therapy alone or in combinat…
… 27, 2025, 55 participants (71% solid tumors, 29% NHL) received HCB101. Treatment-related adverse events (TRAEs) were manageable, most…
…clusions This trial demonstrates that annual revaccination with Nous-209 is safe, and effectively boosts neoantigen-specific T cell resp…
1338 Multi-cohort phase II study of autologous centrally manufactured tumor infiltrating lymphocytes
…neration. After successful TIL production, lymphodepletion with cyclophosphamide (60mg/kg/day IV on days -7 and -6) and fludarabine (25mg/m2 IV …